More recently, our group has clarified the anti-cancer role of CBD and THC, and of the endocannabinoid anandamide (AEA) in MCF-7aro cells, unveiling their mechanism of action and their ability to modulate key targets, such as aromatase, ERα, and ERβ [42,64,65]. The gene discussed is CYP19A1; the disease is cancer.